Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Avsystems Inc. currently manages 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This matter is assigned to 1 distinct examiner across 1 distinct art unit, indicating a concentrated prosecution focus for the company's current intellectual property efforts. The alignment of the action to a single examiner suggests a straightforward review path without the complexities of multi-examiner coordination.
The busiest examiner for the portfolio is EDWARDS, JESSICA FAYE. This individual is responsible for the 1 pending office action currently active for the company. Because there is only one such matter, this examiner handles the entirety of the current workload at the patent office. This concentration allows for a singular focus on the specific requirements and feedback provided by this examiner.
Practitioners should note that the presence of 1 distinct art unit and 1 distinct examiner creates a narrow prosecution environment. There are no other active matters to compare against, making the interactions with EDWARDS, JESSICA FAYE the primary driver of the portfolio's progress. The 1 pending office action assigned to the busiest examiner represents the total current activity in the Biotechnology & Pharmaceuticals sector for this entity.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| EDWARDS, JESSICA FAYE | 1 | 40.0% | +51.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18723722 | AGENT OF ANTI-INFECTIVE TREATMENT OF HUMANS OR ANIMALS, ITS MANUFACTURING METHOD AND USE | EDWARDS, JESSICA FAYE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18723722 | AGENT OF ANTI-INFECTIVE TREATMENT OF HUMANS OR ANIMALS, ITS MANUFACTURING METHOD AND USE | EDWARDS, JESSICA FAYE | — |
| Art Unit | Apps |
|---|---|
| 1657 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18723722 | AGENT OF ANTI-INFECTIVE TREATMENT OF HUMANS OR ANIMALS, ITS MANUFACTURING METHOD AND USE | EDWARDS, JESSICA FAYE | 1657 | §102§103§112 | Non-Final OA | — | Pending | Jun 24, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialAvsystems Inc. has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.
Jessica Faye Edwards has the most, with 1 of Avsystems Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.